Feburic, Samsca, and More Face First Generics in June Listing, No Xarelto/Eylea AGs

A total of 12 brand-name drugs (APIs) will see their first generics join the NHI price list on June 17, including Teijin Pharma’s Feburic (febuxostat), Otsuka Pharmaceutical’s Samsca (tolvaptan), and Asahi Kasei Pharma’s Teribone (teriparatide). According to a listing roster...read more